Cellectar Biosciences, Inc. Payments of Stock Issuance Costs
Cellectar Biosciences, Inc. (CLRB) reported Payments of Stock Issuance Costs of $116.34 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-21.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2018-03-21
- Cellectar Biosciences, Inc. payments of stock issuance costs for the quarter ending 2017-12-31 was $116.34K, a 33.94% decline year-over-year.
- Cellectar Biosciences, Inc. payments of stock issuance costs for the quarter ending 2017-09-30 was $0.00.
- Cellectar Biosciences, Inc. payments of stock issuance costs for the quarter ending 2017-06-30 was $0.00, a 100.00% decline year-over-year.
- Cellectar Biosciences, Inc. payments of stock issuance costs for the quarter ending 2017-03-31 was $0.00, a 100.00% decline year-over-year.
- Cellectar Biosciences, Inc. payments of stock issuance costs for fiscal 2017 was $116.34K, a 64.39% decline from fiscal 2016.
- Cellectar Biosciences, Inc. payments of stock issuance costs for fiscal 2016 was $326.74K, a 24.39% decline from fiscal 2015.
- Cellectar Biosciences, Inc. payments of stock issuance costs for fiscal 2015 was $432.16K, a 16.70% decline from fiscal 2014.
- Cellectar Biosciences, Inc. payments of stock issuance costs for fiscal 2014 was $518.82K.
| Period end | Payments of Stock Issuance Costs 1 month | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|---|
| 2017-12-31 | $116.34K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-21 | $116.34K derived: sum of 2 quarters · filed 2018-03-21 | $116.34K derived: sum of 3 quarters · filed 2018-03-21 | $116.34K 10-K · filed 2018-03-21 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $0.00 derived: sum of 2 quarters · filed 2017-11-09 | $0.00 10-Q · filed 2017-11-09 | $176.10K derived: sum of 4 quarters · filed 2018-03-21 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $0.00 10-Q · filed 2017-08-14 | $176.10K derived: sum of 3 quarters · filed 2018-03-21 | $176.10K derived: sum of 4 quarters · filed 2018-03-21 | |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-11 | $176.10K derived: sum of 2 quarters · filed 2018-03-21 | $176.10K derived: sum of 3 quarters · filed 2018-03-21 | $257.29K derived: sum of 4 quarters · filed 2018-03-21 | |
| 2016-12-31 | $176.10K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-21 | $176.10K derived: sum of 2 quarters · filed 2018-03-21 | $257.29K derived: sum of 3 quarters · filed 2018-03-21 | $326.74K 10-K · filed 2018-03-21 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $81.18K derived: sum of 2 quarters · filed 2017-11-09 | $150.63K 10-Q · filed 2017-11-09 | $582.79K derived: sum of 4 quarters · filed 2017-11-09 | |
| 2016-06-30 | $81.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $150.63K 10-Q · filed 2017-08-14 | $582.79K derived: sum of 3 quarters · filed 2017-08-14 | $582.79K derived: sum of 4 quarters · filed 2017-08-14 | |
| 2016-03-31 | $69.45K 10-Q · filed 2017-05-11 | $501.61K derived: sum of 2 quarters · filed 2017-05-11 | $501.61K derived: sum of 3 quarters · filed 2017-05-11 | ||
| 2015-12-31 | $432.16K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $432.16K derived: sum of 2 quarters · filed 2017-03-15 | $432.16K 10-K · filed 2017-03-15 | ||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $0.00 10-Q · filed 2016-11-10 | |||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-11 | ||||
| 2014-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-10-20 | $518.82K 10-K/A · filed 2016-10-20 | |||
| 2014-09-30 | $518.82K 10-Q · filed 2015-11-12 | ||||
| 2014-08-20 | $1.60M 10-Q · filed 2015-05-20 | ||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-05-20 | $0.00 10-K · filed 2015-05-20 | |||
| 2013-09-30 | $0.00 10-Q · filed 2015-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |